Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

about

Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

Item

http://www.wikidata.org/entity/Q39628955

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@en

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@nl

type

Item

label

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@en

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@nl

prefLabel

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@en

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@nl

P1476

Beyond Composite Endpoints Ana ...... Framework for Cancer Research.

@en

P2093

Daniel J Sargent

http://www.w3.org/2001/XMLSchema#string

Deborah Schrag

http://www.w3.org/2001/XMLSchema#string

Ina Jazić

http://www.w3.org/2001/XMLSchema#string

Sebastien Haneuse

http://www.w3.org/2001/XMLSchema#string

P2860

Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.

Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

A missing data approach to semi-competing risks problems.

Regression modeling of semicompeting risks data.

Multi-state models for the analysis of time-to-event data.

Statistical analysis of illness-death processes and semicompeting risks data.

A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study

A joint test for progression and survival with interval-censored data from a cancer clinical trial

Identification and estimation of survivor average causal effects

P31

scholarly article

P356

10.1093/JNCI/DJW154

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27381741

http://www.w3.org/2001/XMLSchema#string

P932

5241896

http://www.w3.org/2001/XMLSchema#string